<2> Talking Trash: The Incomplete Competing Interests Statement in Keteyian et al. (2016)
<3> Conflicts of Interest in Medical Research: A Growing Concern
The integrity of medical research relies heavily on the transparency of competing interests. In a 2016 editorial published in the British Medical Journal (BMJ), Courtland K Keteyian and colleagues discussed the importance of addressing conflicts of interest in medical research. < href='https://who.int/trialsearch' target='_blank'>WHO defines conflicts of interest as situations where an individual’s personal interests may influence their judgment or actions in a way that could impact the integrity of research. However, in their editorial, Keteyian et al. failed to disclose a crucial piece of information that raises questions about the validity of their argument.
<3> The Omitted Disclosure: Marschall S Runge’s Board Membership
The competing interests statement in Keteyian et al.’s editorial was incomplete. The authors failed to disclose that Marschall S Runge, one of the co-authors, was a member of the board of directors of Eli Lilly. This omission is significant because Eli Lilly is a pharmaceutical company that has a vested interest in the outcomes of medical research. The company